✦ LIBER ✦

Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I

✍ Scribed by A. T. Anbu; J. Mercer; J. E. Wraith

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose-optimization trial of laronidase

✍ Roberto Giugliani; Verónica Muñoz Rojas; Ana Maria Martins; Eugênia R. Valadares 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Laronidase approved for mucopolysacchari

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

28 Safety and efficacy of laronidase in

✍ Michael Beck; J.E. Wraith; R. Lane; A. van der Ploeg; E. Shapiro; N. Guffon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase III Extension Study of Aldurazym

✍ L.A. Clarke; J.E. Wraith; M. Beck; E.H. Kolodny; G.M. Pastores; J. Muenzer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Changes in hair morphology of mucopolysa

✍ Anna Kloska; Jerzy Bohdanowicz; Grażyna Konopa; Anna Tylki-Szymńska; Joanna Jakó 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Cochrane Database of Systematic Reviews

✍ Jameson, Elisabeth 📂 Article 📅 2013 🏛 John Wiley & Sons, Ltd ⚖ 257 KB